By analyzing gene signatures in The Cancer Genome Atlas, it was identified that increased E2F Transcription Factor 1 (E2F1) and increased E2F Transcription Factor 2 (E2F2), two members of the E2F family, were correlated with a loss of function of Rb in ER+ breast cancers [48]. This evidence concerns the gene E2F1 and breast carcinoma.